Company ProfilePremium

Andromeda Metals Limited

Company Profile Analysis

Ticker: ADN.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Andromeda Metals Limited - Company showcase

Year Founded & Workforce

1993

3 Employees

Andromeda Metals Limited logo

Andromeda Metals Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Andromeda Metals Limited Overview

Andromeda Metals is an Adelaide-based, ASX-listed industrial-minerals developer whose value rests almost entirely on the 100%-owned Great White Project (GWP) on South Australia's Eyre Peninsula — a fully permitted, high-grade kaolin and halloysite-kaolin deposit with a planned 28-year mine life and staged capacity of up to 330,000 tonnes per annum of refined kaolin. The company's commercial thesis is to supply premium ceramic-grade kaolin (Great White CRM™) and a low-carbon concrete additive (Great White HRM™) into a market it characterises as structurally under-supplied, underpinned by binding offtakes including with global trader Traxys. A second, potentially larger leg is a proprietary process for producing 4N high-purity alumina (HPA) from Great White kaolin, now at pilot-plant stage. Andromeda has not yet reached a final investment decision: its cash balance is thin, its Middle East cornerstone equity process has stalled, and its market value trades at a steep discount to book.


What the company does

Andromeda is a mineral exploration and development company. It does not yet produce or sell product at commercial scale and reports no operating revenue. Its activities fall into three buckets:

  1. Great White Project (GWP) — kaolin development. Construction-ready mine and wet-processing plant near Poochera / Streaky Bay, South Australia, designed to mine kaolinised granite, refine it on site, and ship refined kaolin products to ceramics and concrete customers. All key permits are in place, feasibility studies are complete, and offtakes cover Stage 1A+ volumes.

  2. High Purity Alumina (HPA) Project. A proprietary acid-leach-type flowsheet (details not fully disclosed) converting Great White kaolin into 4N (≥99.99%) alumina, with laboratory purity of 99.9985% reported and a continuous pilot plant commissioned in July 2026. Potential co-products include amorphous silica and gallium.

  3. Regional exploration and portfolio. A 51% interest in the Eyre Kaolin joint venture (acquired July 2024), the Mount Hope kaolin project, and legacy holdings, alongside a history of divesting non-core gold and copper assets.

Business and revenue model (planned)

Revenue streamModelStatus (Oct 2026)
Refined kaolin (Great White CRM™, KCM™90)Product sales under multi-year offtake (FOB/CFR), priced per wet/dry metric tonnePre-production; offtakes signed for Stage 1A+
Great White HRM™ (metakaolin-type concrete additive)Product sales under conditional offtakesPre-production; conditional agreements
Industrial sand co-productBulk product salesPre-production
HPA (4N)Product sales to LED, battery separator, semiconductor and specialty-ceramic customersPilot stage; commercial samples targeted 2H 2026
Co-products (amorphous silica, gallium)Potential product salesUnder evaluation in pilot program
Licensing / servicesNone disclosed—

The current mix is therefore 100% prospective product revenue; there is no service, subscription or licensing revenue. Reported "income" in recent years consists of interest, R&D tax incentive-related items, sample sales and other sundry income (for example, total income of about A$0.76m in FY2025 per the FY2025 Annual Report; A$0.53m in the six months to 31 December 2024; A$0.72m in the six months to 31 December 2023).

Value-chain position

Andromeda sits at the upstream end of the industrial-minerals chain: mining, beneficiation (wet processing to remove quartz and impurities) and, prospectively, downstream chemical refining (HPA). Its customers are processors and manufacturers — tile, sanitaryware and porcelain makers; concrete and cement product producers; and, for HPA, makers of sapphire substrates, lithium-ion battery separator coatings, phosphors and semiconductor components. Traxys, a commodity trading house, acts as offtaker and marketing intermediary for parts of Asia, India and the Middle East.

Customer types and end-markets

End-marketProductDemand driver
Premium ceramics (porcelain tiles, sanitaryware, tableware)Great White CRM™, KCM™90Whiteness/brightness, low iron and titanium, plasticity; long-term depletion of traditional high-quality kaolin sources (company view)
Concrete / cementGreat White HRM™Decarbonisation of concrete via supplementary cementitious materials
Industrial sandSand co-productConstruction and industrial uses
HPA end-uses4N HPALED sapphire, Li-ion battery separator coatings, semiconductors

Company's own description vs. independent characterisation

The company describes its ambition as becoming "The Great White Mineral Company" and a leading global supplier of industrial minerals, with the GWP described as a high-grade, development-ready, Tier 1 kaolin asset (FY2024 and FY2025 Annual Reports; company materials).

Independent characterisation: Andromeda is a micro-cap, single-asset, pre-FID development company with a technically de-risked but unfunded project. The key constraint is not geology or permitting but capital: the company has repeatedly come close to financing (A$75m Merricks Capital credit approval in June 2025; a Middle East cornerstone investor in final negotiations in early 2026) without closing. The HPA strategy is strategically logical — it lifts potential value per tonne of kaolin dramatically — but it also adds a second capital requirement (~A$155m pre-production capex per the 2025 Scoping Study) to a company with ~A$3m of cash at 30 June 2026.

Strategy

Stated strategy (themes from FY2024–FY2025 Annual Reports and 2026 updates)

  1. Develop the Great White Project in stages (Stage 1A+ 100ktpa → Stage 1B +110ktpa → Stage 2 +120ktpa; up to 330ktpa refined kaolin), capturing value through on-site refining rather than direct-shipping ore.

  2. Target premium, high-value markets (ceramics, low-carbon concrete) where Great White's quality commands top-of-range kaolin pricing.

  3. Commercialise HPA as a critical-mineral growth leg, creating a new supply chain independent of traditional bauxite/aluminium routes.

  4. Fund development via a mix of senior debt (Merricks), strategic/cornerstone equity at asset level, offtaker support (Traxys subordinated facility) and government incentives (R&D Tax Incentive; potential critical minerals grants).

  5. Maintain capital discipline: cost reductions of ~A$3m identified in 2026; postponement of non-essential exploration.

Initiatives in the last 24 months

InitiativeDateDetailStatus
Merricks Capital A$75m senior debt facilityCredit approval 4 Jun 2025Staged drawdown; senior security over project; 400m warrants at a 10% premium to development equity priceSubject to equity funding and documentation; not drawn
Global cornerstone equity process2025–2026Middle East-based institution; asset-level investment across GWP and HPA; due diligence completeDisrupted by Middle East conflict (Q1 2026); alternatives assessed in parallel
Stage 1A+ detailed engineering and plant optimisation2,025Plant design optimised for product quality and cost; production stages consolidated to lift capacity; capex review showed no material changeComplete
GWP early worksOct 2025 – Jul 2026Site clearance, topsoil stockpiling, mine access track, fencing, stormwater pond, plant pad bulk earthworks, drill-and-blast trial, grade-control drilling, long-lead equipment transportComplete; remaining funding requirement ~A$40m (April 2026 estimate)
HPA Scoping Study18 Sep 202510ktpa 4N HPA; NPV10 post-tax A$1.01bnComplete
HPA pilot plantJun–Jul 2026Continuous flowsheet; co-product evaluationCommissioned; testwork underway
HPA commercial samples and marketing2H 20264N samples for customer qualificationTargeted
HPA Pre-Feasibility Study2H 2026Subject to funding; supported by Sep 2026 SPPPlanned
Cost-reduction programMar 2026~A$3m savings across early works, procurement and adminImplemented
ESG / low-carbon positioningOngoingHRM™ for concrete decarbonisation; lower-carbon HPA claimOngoing

Medium-term targets / guidance

  • Stage 1A+ FID: targeted once funding is secured (earlier aspiration of construction in 2H 2025 has slipped).

  • Total Stage 1A+ funding target: ~A$90m plus financing costs, interest and reserves (including ~A$84m capex), per Invest SA project profile; early works have since reduced the remaining requirement to ~A$40m (company, April 2026 — the basis of this figure, e.g. net of debt, should be checked).

  • GWP economics (May 2024 expansion case): post-tax NPV8 A$763m; IRR 43%; average EBITDA ~A$140m p.a. at full staged capacity.

  • No formal earnings guidance. One analyst (as aggregated by Simply Wall St) had projected a loss in FY2026 and a profit of ~A$34m in FY2027 — now clearly stale given the funding delay.

Products & Services

All products are pre-commercial. Pricing models are offtake-based; specific prices are not publicly disclosed beyond the statement that Traxys year 1–2 prices are consistent with 2023 DFS assumptions.

Kaolin products (Great White Project)

Great White CRM™ (Ceramic Raw Material)

  • Description: Refined, wet-processed kaolin for premium ceramics; the core volume product for Stage 1A+.

  • Key specifications: High whiteness and fired brightness, low iron/titanium; marketed for its ability to partially displace zircon opacifiers in ceramic glazes/bodies (company claims).

  • Target customers: Porcelain tile, sanitaryware and tableware producers in Asia, the Middle East, India and Europe.

  • Offtakes: Binding agreements including Traxys Europe S.A. (July 2024) — 25,000 wmt in year 1 and 40,000 wmt in year 2, with year-3-onward volumes at higher levels (±10% at Traxys' option); pricing upside on Traxys' on-sales shared equally; prices from year 3 subject to annual negotiation. An earlier binding agreement contemplated 115,000 tonnes of CRM™ over five years. A Chinese distributor agreement was referenced for the China market, with India and Middle East sales of CRM™ managed by Traxys.

  • Launch: Not yet launched; production targeted after FID.

Great White KCM™90

  • Description: High-specification kaolin ceramic product (core product per 2023 strategy review).

  • Offtake: 5,000 tonnes in the first year of production under a signed agreement (Half-Year Report, Dec 2023).

  • Target customers: High-end ceramics manufacturers.

Great White HRM™

  • Description: A halloysite-kaolin-derived reactive additive designed to help decarbonise concrete (supplementary cementitious material); also historically marketed as a rheology modifier.

  • Offtake: Conditional agreements for 5,000–10,000 wmt p.a. into concrete applications (subject to a market acceptance condition precedent in favour of the buyer).

  • Target customers: Concrete and cement product manufacturers.

Industrial sand co-product

  • Description: Quartz sand separated during wet processing.

  • Target customers: Construction and industrial users.

  • Commercial terms: Not publicly disclosed.

High Purity Alumina (HPA)

4N HPA (≥99.99% Al₂O₃)

  • Description: Produced from Great White kaolin via a proprietary process the company describes as lower-cost and lower-carbon than incumbent routes; the company states it can tailor morphology and product form.

  • Key capabilities: Lab purity 99.9985%; continuous pilot plant commissioned July 2026; commercial samples targeted for customer evaluation in 2H 2026.

  • Scoping Study (Sept 2025): 10,000tpa HPA using ~30,000tpa of kaolin feedstock (sourced arm's-length from GWP); 24-year life; pre-production capex ~A$155m (~A$159m total with ~30% contingency per media summary); capital intensity ~A$15,459/t capacity; operating cost ~A$4,718/t (excluding silica by-product credits); NPV10 A$1.48bn pre-tax / A$1.01bn post-tax; post-tax IRR ~69%; a 20% change in HPA price moves NPV by ~26%.

  • Target customers: LED/sapphire, Li-ion battery separator coating, semiconductor and specialty materials producers.

Amorphous silica (potential co-product)

  • Being evaluated in the pilot program; the company has signalled possible reclassification from by-product to high-value co-product.

Gallium (potential co-product)

  • Recovery potential under evaluation, framed against Chinese export controls on gallium (imposed from 2023).

Halloysite / nanotechnology (legacy R&D)

  • Halloysite nanotube applications (carbon capture, hydrogen storage, environmental remediation, slow-release fertilisers) were promoted in 2021–2023, including through the Natural Nanotech entity and a research agreement on carbon capture referenced in the FY2023 Annual Report. These are not currently central to the commercial plan.

Financial Narrative

Source: S&P Global Market Intelligence data (via StockAnalysis.com), cross-checked to FY2023–FY2025 Annual Reports and half-year reports where available. FY2026 figures derived from S&P data incorporating the H1 FY2026 half-year report (lodged 16 March 2026) and FY2026 annual results (released c. 6 October 2026). All figures A$ millions unless noted.

Income statement

Notes: FY2026 EPS is S&P's rounded A$-0.02; Simply Wall St reported A$-0.023 on a trailing basis to December 2025. Half-year net results: H1 FY2025 -2.34; H2 FY2025 -3.70; H1 FY2026 -101.58; H2 FY2026 -3.46. Margins (gross, operating, EBITDA, net) and revenue CAGR are not meaningful at zero revenue. Earlier-year EBITDA figures differ slightly by provider (TipRanks shows FY2023 -10.58 and FY2022 -8.30), reflecting differing treatment of exploration write-offs.

Commentary. Underlying cash operating losses have trended down steadily — EBITDA improved from about -A$8.9m in FY2023 to about -A$5.6m to -A$6.2m in FY2025–FY2026 — reflecting cost discipline as the company shifted from a large corporate team building for production to a lean, financing-focused structure. The dominant feature of FY2026 is a ~A$99m non-cash charge booked in the half to 31 December 2025, which S&P classifies within depreciation, amortisation and impairment. Property, plant and equipment (which in S&P's taxonomy includes capitalised exploration, evaluation and development assets) fell from A$150.6m at 30 June 2025 to A$54.4m at 31 December 2025, and equity fell from A$157.9m to A$69.6m. Analytically, the write-down brings book value closer to market value but does not change the project's physical or permitting status.

Balance sheet

Notes: FY2026 share count is the 31 December 2025 figure (4,621m); additional small issues in January and April 2026 are possible. The September 2026 SPP added ~516m shares, taking the total to ~5.14bn. Interim balance at 31 December 2025: cash A$10.06m, PP&E A$54.35m, total assets A$71.66m, equity A$69.62m.

Commentary. The balance sheet is debt-free apart from small office/equipment leases, which is a genuine strength, but liquidity is now critical: cash fell to ~A$3.2m at 30 June 2026 against an annual free-cash outflow of ~A$14m in FY2026. The A$3.04m raised in September 2026 provides only a few months of runway at FY2026 burn rates, although management has cut ~A$3m of costs and completed most early-works spending. The equity base was cut by more than half by the H1 FY2026 write-down.

Cash flow

Notes: Capex derived as FCF minus OCF. FY2023 OCF shown by TipRanks as -8.78 vs -9.13 (S&P) — discrepancy noted. FY2026 net change in cash computed from balance sheet (7.14 to 3.20). Half-year FCF: H1 FY2026 -6.27; H2 FY2026 -7.92.

Commentary. Capital expenditure rose in FY2026 (to ~A$9.0m) as early works, bulk earthworks for the Stage 1A+ plant pad, a drill-and-blast program, grade-control drilling and transport of long-lead items were executed, along with the HPA pilot plant. R&D tax refunds (A$2.34m for FY2024, received early 2025; A$1.66m for FY2025, received May 2026) are a recurring non-dilutive cash source but are small relative to burn.

Ratios

Notes: FY2022–FY2025 ROE/ROA computed on average equity/assets from the tables above; FY2026 ROE, ROA and current ratio as reported by S&P Global. ROIC (S&P, FY2026): -58.6%. Net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle: not meaningful (net cash, no revenue, negligible interest).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Results by Segment and Revenue by Segment (%)

SegmentFY2024FY2025FY2026

Mineral exploration & development, Australia — operating revenue (AUD Mn)

000

Mineral exploration & development, Australia — pre-tax result (AUD Mn)

-7.27-6.04-105.03

Share of total revenue (%)

100100100

Unit / Project Details

Unit / projectOwnershipContentsStage

Great White Project (GWP)

100%

Great White deposit; three mining tenements and three exploration tenements; Streaky Bay Pilot Plant; Stage 1A+ plant pad

Construction-ready; early works complete; awaiting FID funding

HPA Project

100% (company); cornerstone discussions contemplated asset-level investment

Proprietary HPA flowsheet; pilot plant; 2025 Scoping Study

Pilot testwork; PFS planned subject to funding

Eyre Kaolin Project (JV)

51% (acquired July 2024)

Regional kaolin tenements

Exploration; sample analysis postponed (June 2026 quarter) for cost reasons

Mount Hope Kaolin Project

Interest per company reports

Kaolin exploration

Exploration

Legacy / divested assets

Divested or non-core

Wudinna gold (sold to Cobra Resources), Moonta copper-gold, Drummond epithermal gold (Qld)

Divestment program

Income Statement and Share Count (m)

MetricFY2022FY2023FY2024FY2025FY2026

Operating revenue (AUD Mn)

00000

Gross profit (AUD Mn)

00000

SG&A expense (AUD Mn)

5.387.456.634.99—

R&D expense (AUD Mn)

0.852.840.820.73—

Operating income / EBIT (AUD Mn)

-8.41-9.89-7.54-5.94-105.28

EBITDA (AUD Mn)

-7.88-8.94-6.45-5.62-6.18

D&A and impairment charges (AUD Mn)

0.520.941.090.3299.10

Pre-tax income (AUD Mn)

-8.73-9.46-7.27-6.04-105.03

Net income (AUD Mn)

-8.73-9.46-7.27-6.04-105.03

Weighted avg shares, basic (m)

2,6623,1103,1103,418—

EPS basic (A$ cents)

-0.33-0.30-0.23-0.18-2.0

Dividends per share (AUD)

00000

Balance Sheet and Share Count (m)

MetricFY2022FY2023FY2024FY2025FY2026

Cash & equivalents (AUD Mn)

32.8515.305.447.143.20

Total current assets (AUD Mn)

34.3519.896.148.79—

PP&E incl. capitalised project assets (AUD Mn)

139.50144.84149.94150.59—

Total assets (AUD Mn)

174.22165.03158.07160.21—

Total debt — leases only (AUD Mn)

0.850.730.580.370.15

Short-term debt / current leases (AUD Mn)

0.170.200.220.21—

Long-term debt / non-current leases (AUD Mn)

0.680.530.370.15—

Net cash (AUD Mn)

32.0114.574.856.783.05

Total liabilities (AUD Mn)

3.032.873.192.27—

Shareholders' equity (AUD Mn)

171.19162.16154.88157.9366.20

Goodwill & intangibles (AUD Mn)

00000

Working capital (AUD Mn)

32.0317.653.436.863.54

Shares outstanding at period end (m)

3,1063,1083,1083,8134,621

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (AUD Mn)

-5.14-9.13-5.05-4.77-5.17

Capital expenditure (AUD Mn)

-5.11-8.60-7.90-4.28-9.01

Free cash flow (AUD Mn)

-10.25-17.73-12.95-9.05-14.18

Investing cash flow (AUD Mn)

-9.83-8.19-4.56-1.40—

Financing cash flow (AUD Mn)

42.92-0.22-0.257.87—

Net change in cash (AUD Mn)

27.95-17.55-9.861.71-3.94

Dividends paid (AUD Mn)

00000

Share buybacks (AUD Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%)

-9.30-5.68-4.59-3.86-93.72

ROA (%)

-9.09-5.58-4.50-3.80-57.66

Current ratio (x)

14.818.882.264.553.60

Debt / equity (x)

0.0050.0050.0040.0020.002

Geographic Revenue

RegionFY2024FY2025FY2026

Australia — operating revenue (AUD Mn)

000

Asia-Pacific ex-Australia — operating revenue (AUD Mn)

000

EMEA — operating revenue (AUD Mn)

000

Americas — operating revenue (AUD Mn)

000

Capital Markets

MeasureValueDate / source

Current price

A$0.006

7 Oct 2026 (S&P via StockAnalysis)

52-week change

-68.4%

7 Oct 2026 (S&P)

1-year change (alternative)

+28.6%

Simply Wall St, early 2026 snapshot (different base date)

3-year change

-81.6%

Simply Wall St, early 2026 snapshot

5-year change

-96.9%

Simply Wall St, early 2026 snapshot

5-year beta

2.09

S&P

Average daily volume (20-day)

~3.6m shares

S&P

Share Count (m) and Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Shares outstanding at year end (m)

3,1063,1083,1083,8134,621

Equity raised, approx. (AUD Mn)

4300816

Valuation Multiples

MultipleAndromedaPeer comparison

P/E

n/m (loss)

n/m

EV/EBITDA

n/m (negative EBITDA)

n/m

EV/Sales

n/m

n/m

P/B

0.47x (on post-write-down equity of A$66.2m)

—

EV vs. study NPV

EV ~A$27.8m vs GWP post-tax NPV8 A$763m (May 2024) — ~4% of study NPV

Typical pre-FID developers trade at a fraction of NPV; the discount here is extreme

Analyst Conclusions

Management guidance

  • HPA: complete pilot testwork, produce commercial 4N samples for customer evaluation in 2H 2026, and progress a PFS subject to funding.

  • GWP: secure cornerstone equity (or alternatives) to reach FID for Stage 1A+; Merricks A$75m facility remains credit-approved but conditional.

  • Corporate: appoint a permanent CEO; maintain ~A$3m cost savings.

  • No quantitative earnings, production or capex guidance for FY2027.

Consensus

No reliable consensus exists. A previously aggregated forecast of a ~A$34m profit in FY2027 should be disregarded as stale given that FID has not occurred.

Bull case

  1. Deep value vs. de-risked asset: EV of ~A$28m against a permitted project with post-tax NPV8 of A$763m and completed early works implies large re-rating potential if funding closes.

  2. HPA could transform the equity story: A successful pilot and customer qualification of a low-cost (~A$4,718/t opex) kaolin-to-HPA process, plus gallium/silica credits, could attract strategic capital at the asset level independent of the kaolin project.

  3. Funding architecture largely built: Debt is credit-approved, offtakes are signed, R&D incentive Advance Finding is in place; the missing piece is a single equity cheque (~A$40m remaining requirement per April 2026 update).

Bear case

  1. Financing has failed repeatedly: Construction was targeted for 2H 2025; by October 2026 there is still no FID, and the cornerstone investor has been hit by regional conflict.

  2. Existential dilution: With ~A$3m of cash post-June 2026 plus A$3m raised in September and annual burn above A$10m, further raises at sub-cent prices are likely, eroding any eventual upside per share.

  3. Write-down signals scepticism: The ~A$99m impairment and P/B of 0.47x suggest both accountants and markets doubt the recoverability of historical capitalised costs on current funding prospects.

Catalysts and monitorables (next 12 months)

CatalystExpected timing
September 2026 quarterly report (cash, funding status)Late Oct 2026
2026 AGM (board composition, remuneration votes)Nov 2026 (expected)
Commercial 4N HPA samples delivered to customers2H 2026
Permanent CEO appointmentPending
Cornerstone equity agreement / alternative fundingUnscheduled
Merricks facility documentation and financial closeContingent on equity
HPA PFS commencement and results2H 2026 start; results likely 2027
Gallium/silica co-product results from pilot2H 2026
Further capital raises and dilutionLikely within 6 months
Going-concern language in FY2026 audit reportReleased with Annual Report

Analyst verdict

Andromeda Metals presents a stark divergence between asset quality and corporate condition. On the asset side, the Great White Project is about as de-risked as a pre-FID industrial-minerals project can be: tenure and approvals are in place, feasibility work has been iterated through a DFS and an expansion study, site early works are finished, long-lead equipment is on site, and Stage 1A+ volumes are fully covered by binding offtakes including a global trading house. The HPA leg adds credible, if unproven, upside, and the July 2026 pilot commissioning is a genuine technical step forward.

On the corporate side, however, the company is fragile. Cash at 30 June 2026 was roughly A$3.2m, free cash outflow was about A$14m in FY2026, and the September 2026 SPP raised only A$3m. The ~A$99m write-down in the December 2025 half signals that management and auditors could no longer support historical carrying values on current funding visibility. The board is small, the chief executive role has been filled on an acting basis for two years, and the cornerstone investor on which FID depended has been disrupted by events entirely outside the company's control.

The equity therefore behaves like a binary option on a funding event. If a cornerstone or strategic partner commits at the asset level, the Merricks facility, warrants and offtakes can fall into place quickly and the market value — currently around 4% of the 2024 study NPV — could re-rate sharply, though existing shareholders would likely be diluted at the asset or parent level. If funding does not materialise within the next two to three quarters, the company faces continued sub-cent raises, possible asset-level sell-downs on weak terms, or a strategic transaction at a low valuation.

Verdict: High-risk, speculative special situation. Monitor the September quarterly, HPA sample feedback and any funding announcement; fundamentals do not support a position without clear evidence that FID financing is in hand.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles / backgroundEducation

Sue-Ann Higgins

Executive Chair

Director since Feb 2024; Executive Chair since Sep 2024

Senior resources executive; leads board through CEO search and financing

—

Sarah Clarke

Acting CEO; General Counsel & Company Secretary

GC/CoSec since Jan 2023; Acting CEO since Sep 2024

Corporate/resources lawyer

LLB (Hons), BSc, Grad Cert (Applied Finance & Investment)

Keith Pollocks

Chief Financial Officer

From 20 Jul 2026

30+ years in finance leadership across SolGold, Kasbah Resources, Newcastle Coal Infrastructure Group, MMG, LyondellBasell, Shell and Lloyds Bank; project finance and capital markets experience across ASX, HKEX, TSX and LSE-listed companies

—

Joseph (Joe) Ranford

—

From Apr 2020

GM Angas Zinc Mine (Terramin), COO Otso Gold, GM Extension Hill (MGX), COO Compass Gold, GM Australian Ops (Crocodile Gold); AusIMM member

MBA (University of Adelaide)

Board of Directors

NameRoleIndependenceAppointed / notes

Sue-Ann Higgins

Executive Chair

Not independent (executive)

2024

Mick Wilkes

Non-executive Director (former Chair)

—

Former Chair; waived director fees from Sep 2024 until project financing secured

Jean-Dominique Sorel

Non-executive Director

Not independent in substance given Traxys alignment (verify)

Industrial minerals veteran (45+ years); appointment linked to Traxys partnership

Miguel Galindo

Non-executive Director

—

Appointed 16 Jan 2025

Executive Leadership Team by Person

PersonTotalSource / year

Executive Chair (Higgins)

~A$149,690

Simply Wall St (FY2025 basis)

Other NEDs

Reported totals of ~A$16.7k, ~A$99.3k and ~A$177.2k (names not mapped)

Simply Wall St

Major Shareholders

CategoryStakeSource

Insiders

~7.10%

S&P Global (Oct 2026)

Institutions

~1.34%

S&P Global (Oct 2026)

Free float

~4.63bn shares

S&P Global

Acting CEO direct holding

~0.02%

Simply Wall St

Competitive Landscape

Competitors by Segment

SegmentCompetitorListingPositioning vs. Andromeda

Kaolin (global)

Imerys

Euronext Paris (NK)

Global leader in performance minerals and kaolin; vastly larger, integrated, producing

Kaolin (global)

Sibelco

Private (Belgium)

Major global industrial minerals producer incl. ceramic clays and kaolin

Kaolin (US)

KaMin / CADAM (acquired BASF's kaolin business 2022)

Private

Large US/Brazil kaolin producer

Kaolin (US)

Thiele Kaolin

Private

US Georgia kaolin producer

Kaolin (Europe)

LB Minerals; Quarzwerke / Amberger Kaolinwerke

Private

European ceramic kaolin supply

Kaolin (India)

Ashapura Minechem; English India Clays (EICL)

NSE/BSE

Regional producers in Traxys target markets

Kaolin (Australia, junior)

Suvo Strategic Minerals

ASX: SUV

Australian kaolin producer/developer (Pittong, Victoria)

Halloysite-kaolin (junior)

Latin Resources' former Noombenberry project (now under Pilbara Minerals ownership following 2025 acquisition — verify)

—

Peer halloysite-kaolin asset in WA

HPA (incumbent)

Sumitomo Chemical; Sasol; Baikowski; Nippon Light Metal

Various

Established HPA producers using alkoxide/alum routes

HPA (Australian developers)

Alpha HPA (ASX: A4N); FYI Resources (ASX: FYI); Altech Batteries (ASX: ATC); Impact Minerals (ASX: IPT)

ASX

Competing Australian HPA developers; Alpha HPA is materially more advanced (construction/production)

Key Competitors

CompanyRevenueStage

Andromeda Metals (FY2026)

A$0

Pre-FID developer

Imerys (FY2024)

~€3.6bn (approximate; verify)

Major producer

Alpha HPA (latest FY)

—

Building/producing HPA

Suvo Strategic Minerals (latest FY)

—

Small producer

Recent Developments

--

Company Snapshot

3

Employees

1993

Founded

Adelaide, Australia

Headquarters

SWOT Analysis

Strengths

  • Permitted, construction-ready asset: All key permits in place; early works (access track, plant pad earthworks, stormwater pond, long-lead item transport) completed by July 2026.
  • Offtake coverage: Four binding offtakes supporting Stage 1A+, including Traxys (25,000 wmt year 1, 40,000 wmt year 2, higher thereafter).
  • Robust study economics: May 2024 case post-tax NPV8 A$763m, IRR 43%, average EBITDA ~A$140m p.a.
  • HPA optionality: Lab purity 99.9985%; Scoping Study post-tax NPV10 A$1.01bn on ~A$155m pre-production capex.
  • Debt-free balance sheet: Total debt of only ~A$0.15m (leases) at 30 June 2026.
  • Long reserve life: Ore reserve of 15.1Mt supporting a 28-year mine life.
  • Non-dilutive support: AusIndustry Advance Finding covering ~A$26m of eligible R&D at a 43.5% refundable offset; A$4.0m of refunds received across FY2025–FY2026.

Weaknesses

  • Liquidity: Cash only ~A$3.2m at 30 June 2026 vs FY2026 FCF of -A$14.2m.
  • Persistent dilution: Shares outstanding rose from ~3.1bn (FY2024) to ~5.14bn (Oct 2026); share count +27.6% YoY.
  • Leadership instability: Acting CEO since September 2024; CFO turnover in mid-2026.
  • Write-down: ~A$99m charge in H1 FY2026 cut equity from A$157.9m to ~A$66.2m.
  • No revenue track record: Zero operating revenue across all five years reviewed.
  • Small board: Four directors with limited demonstrated independence.

Opportunities

  • Closing the cornerstone deal: An asset-level investment would unlock the Merricks A$75m facility and FID.
  • HPA commercial samples (2H 2026): Customer qualification could attract strategic partners or offtake prepayments.
  • Co-products: Amorphous silica and gallium could lift HPA project value.
  • Critical-minerals policy support: Australian and allied government funding for HPA and gallium supply chains.
  • Staged expansion: Stage 1B and Stage 2 could triple output to 330ktpa.
  • Regional resource growth: Eyre Kaolin JV (51%) and Mount Hope.

Threats

  • Geopolitics: The Middle East conflict has already derailed the cornerstone process (Q1 2026).
  • Capital markets: Share price of A$0.006 and market cap ~A$31m make large equity raises highly dilutive.
  • HPA competition: More advanced Australian HPA developers could capture early customer qualifications.
  • Kaolin demand cyclicality: Ceramic tile demand tied to construction cycles in China and emerging markets.
  • Going-concern risk: Cash runway measured in months (verify going-concern disclosures in the FY2026 audit report).
  • Delisting/penny-stock dynamics: Very low price and high volatility (5-year beta ~2.1) deter institutional investors.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Exclusive negotiations with Merricks Capital for up to A$75m debtAdvanced debt process
29 Apr 2025March 2025 quarterly: funding progress for Stage 1A+Funding narrative
1 May 2025HPA breakthrough: >99.99% purity at lab scaleOpens critical-minerals leg
May 2025A$5m placement at A$0.013 (23.5% discount); shares fell ~29% that weekDilutive funding for early works and engineering
4 Jun 2025A$75m Merricks facility credit-approvedKey debt milestone
Mid-2025Stage 1A+ engineering optimisation update; capex review shows no material changeDe-risking
29 Sep 2025FY2025 Annual Report: net loss A$6.04m; cash A$7.14mBaseline before FY2026
18 Sep 2025HPA Scoping Study: NPV10 A$1.48bn pre-tax; shares rose ~20% to A$0.024Re-rating catalyst (short-lived)
15 Oct 2025Trading halt for capital raising—
17 Oct 2025A$13m placement completed at A$0.0175 with attaching optionsLargest raise since FY2022
24–27 Oct 2025SPP cleansing notice and offer booklet (target ~A$2.5m)Retail participation
30 Oct 2025September 2025 quarterly; early site works to commence at GWPProject mobilisation
14 Nov 2025Noosa Mining Conference presentationInvestor marketing
18 Nov 2025Funding
20 Nov 2025AGM; constitution updateGovernance
11 Dec 2025Appendix 2A share issuesCapital structure
H1 FY2026~A$99m non-cash write-down of project carrying valuesBook value more than halved
30 Jan 2026December 2025 quarterly reportFunding update
16 Mar 2026Half-Year Report to 31 Dec 2025: net loss ~A$101.6mReflects write-down
31 Mar 2026Company update: cornerstone process delayed by Middle East geopolitical events; ~A$3m cost savings; HPA PFS planned 2H 2026 subject to funding; shares fell to A$0.006–0.008Major setback to FID timeline
15 Apr 2026Early works program completed; remaining funding need ~A$40mConstruction-ready
29 Apr 2026March 2026 quarterly: cornerstone negotiations at final stages but disrupted; investing outflow ~A$3.05mFunding risk elevated
30 Apr 2026CFO Pascal Alexander-Bossy resigns (effective 26 Jun 2026); CEO search "well progressed"Leadership gap
5 May 2026A$1.66m R&D tax refund received for FY2025Non-dilutive cash
22 Jun 2026HPA pilot plant commissioning beginsHPA progress
29 Jun 2026Cessation of securities (options/rights lapse)Capital structure
6 Jul 2026Early works update: transport of long-lead items completeReadiness
13 Jul 2026Keith Pollocks appointed CFO; company update presentationFinance leadership restored
29 Jul 2026HPA pilot plant commissioning complete; optimisation and testwork underwayTechnical de-risking
31 Jul 2026June 2026 quarterly: cash down ~A$2.0m in quarter; Eyre Kaolin sample analysis postponedLiquidity tight
12 Aug 2026SPP to raise ~A$3m at A$0.0059 (≈15% discount) for HPA PFS and working capitalFurther dilution
14 Aug 2026ASX waiver granted for second SPP within 12 monthsRegulatory
17 Aug 2026SPP offer booklet and cleansing notice—
4 Sep 2026A$3.04m raised (A$2.94m SPP from 342 holders + A$0.10m placement)Short runway extension
8 Sep 2026Director interest changes (Higgins, Sorel)Insider participation
c. 6 Oct 2026FY2026 annual results / Annual Report releasedFull-year loss ~A$105m; cash A$3.2m at 30 June

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Revenue by Segment (%): Share of total revenue held from 100% in FY2024 to 100% in FY2026.
Andromeda Metals Limited — Revenue by Segment (%)
Series (%)FY2024FY2025FY2026
Share of total revenue100100100

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. ASX announcement — Andromeda Annual Report 2024 (announcements.asx.com.au)
  2. ASX announcement — Andromeda Annual Report 2023 (announcements.asx.com.au)
  3. ASX announcement — Half-Year Report to 31 Dec 2024 (announcements.asx.com.au)
  4. ASX announcement — Half-Year Report to 31 Dec 2023 (announcements.asx.com.au)
  5. Quarterly Activity Report — March 2026 (bulletin.webull.com)
  6. Quarterly Activity Report — June 2026: and: investorpa.com · investorpa.com
  7. Executive Management Update (30 Apr 2026) (bulletin.webull.com)
  8. Appointment of CFO (13 Jul 2026) (bulletin.webull.com)
  9. HPA Project Update (22 Jun 2026) (bulletin.webull.com)
  10. SPP announcement (12 Aug 2026) (bulletin.webull.com)
  11. ASX waiver (14 Aug 2026) (bulletin.webull.com)
  12. SPP results (4 Sep 2026) (bulletin.webull.com)
  13. InvestSMART announcement summaries (31 Mar, 15 Apr, 29 Apr, 5 May, 22 Jun, 29 Jul, 12 Aug 2026; 30 Oct 2025) (investsmart.com.au)
  14. StockAnalysis.com (S&P Global Market Intelligence data) — financials, statistics · stockanalysis.com · stockanalysis.com · stockanalysis.com
  15. TipRanks — income statement, cash flow, company announcements (tipranks.com)
  16. Simply Wall St — management, ownership, share performance (simplywall.st)
  17. Invest SA — Great White Project profile (invest.sa.gov.au)
  18. Mining Technology — Merricks A$75m facility (mining-technology.com)
  19. Mining Weekly — 2024 CEO resignation (miningweekly.com)
  20. Kalkine — HPA Scoping Study; pilot plant commissioning (kalkine.com.au)
  21. Stockhead — HPA scoping study; DFS reaction (stockhead.com.au)
  22. Small Caps — HPA study opex; Poochera scoping study (smallcaps.com.au)
  23. AL Circle — HPA pilot plant and SPP coverage (alcircle.com)
  24. InDaily — May 2025 placement (develop.indailysa.com.au)
  25. Dealroom/Listcorp — A$13m placement terms (app.dealroom.co)
  26. IBISWorld — corporate identifiers (ibisworld.com)
  27. MarketScreener — COO profile (in.marketscreener.com)
  28. Morningstar Australia — company profile (morningstar.com.au)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.